References
- AlvesGForsaaEBPedersenKFDreetz GjerstadMLarsenJPEpidemiology of Parkinson’s diseaseJ Neurol2008255suppl 5183218787879
- Leyva-GómezGCortésHMagañaJJLeyva-GarcíaNQuintanar-GuerreroDFloránBNanoparticle technology for treatment of Parkinson’s disease: the role of surface phenomena in reaching the brainDrug Discov Today201520782483725701281
- KulkarniADVanjariYHSanchetiKHBelgamwarVSSuranaSJPardeshiCVNanotechnology-mediated nose to brain drug delivery for Parkinson’s disease: a mini reviewJ Drug Target201523977578825758751
- Di StefanoASozioPIannitelliACerasaLSNew drug delivery strategies for improved Parkinson’s disease therapyExpert Opin Drug Deliv20096438940419382882
- GarbayoEAnsorenaEBlanco-PrietoMJDrug development in Parkinson’s disease: from emerging molecules to innovative drug delivery systemsMaturitas201376327227823827471
- SchmidtWJLebsanftHHeindlMContinuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movementsJ Neural Transm (Vienna)2008115101385139218726139
- NeuweltEABauerBFahlkeCEngaging neuroscience to advance translational research in brain barrier biologyNat Rev Neurosci201112316918221331083
- VakaSRShivakumarHNRepkaMAMurthySNFormulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administrationJ Drug Target2013211445323020597
- HeurtaultBFrischBPonsFLiposomes as delivery systems for nasal vaccination: strategies and outcomesExpert Opin Drug Deliv20107782984420459361
- TafaghodiMSajadi TabassiSAJaafariMRInduction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODNInt J Pharm20063191–2374316701972
- WangSChenPZhangLYangCZhaiGFormulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcuminJ Drug Target2012201083184022934854
- GomesMJNevesJSarmentoBNanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous systemInt J Nanomedicine201491757176924741312
- AliJAliMBabootaSPotential of nanoparticulate drug delivery systems by intranasal administrationCurr Pharm Des201016141644165320210751
- VermaAStellacciFEffect of surface properties on nanoparticle-cell interactionsSmall201061122119844908
- WardPPUribe-LunaSConneelyOMLactoferrin and host defenseBiochem Cell Biol20028019510211908649
- ElfingerMMauckschCRudolphCCharacterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cellsBiomaterials200728233448345517475321
- SuzukiYALopezVLonnerdalBMammalian lactoferrin receptors: structure and functionCell Mol Life Sci200562222560257516261254
- QianZMWangQExpression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disordersBrain Res Brain Res Rev19982732572679729418
- JiBMaedaJHiguchiMPharmacokinetics and brain uptake of lactoferrin in ratsLife Sci200678885185516165165
- SharmaDSharmaRKSharmaNNose-to-brain delivery of PLGA-diazepam nanoparticlesAAPS PharmSciTech20151651108112125698083
- HuwylerJWuDPardridgeWMBrain drug delivery of small molecules using immunoliposomesProc Natl Acad Sci U S A1996932414164141698943078
- LiuZJiangMKangTLactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administrationBiomaterials201334153870388123453061
- PahujaRSethKShuklaATrans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian ratsACS Nano2015954850487125825926
- AllenCYuYEisenbergAMaysingerDCellular internalization of PCL(20)-b-PEO(44) block copolymer micellesBiochim Biophys Acta199914211323810561469